lansoprazole has been researched along with histamine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Håkanson, R; Karlsson, A; Lee, H; Mattsson, H; Sundler, F | 1 |
| Inatomi, N; Nagaya, H; Satoh, H | 1 |
| Araki, T; Kakinoki, B; Morinaka, Y; Takeuchi, Y; Uchiyama, K; Wakatsuki, D | 1 |
| Fujiwara, K; Karasuyama, M; Murata, I; Shin, M; Tanabe, T; Ueoka, R | 1 |
| Naseri, E; Yenisehirli, A | 1 |
| Arikawa, Y; Hirase, K; Hori, Y; Imanishi, A; Inatomi, N; Kajino, M; Matsukawa, J; Nishida, H; Tsukimi, Y | 1 |
| Hori, Y; Inatomi, N; Kajino, M; Matsukawa, J; Nishida, H; Takeuchi, T | 1 |
| Hide, M; Ishii, K; Iwamoto, K; Moriwaki, M; Takahagi, S | 1 |
| Chen, Y; Hou, Y; Li, H; Li, S; Lin, J; Liu, T; Ma, Y; Wang, Y; Yang, H; Zhang, X; Zhang, Y; Zhou, L; Zhou, X | 1 |
10 other study(ies) available for lansoprazole and histamine
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Lansoprazole and omeprazole have similar effects on plasma gastrin levels, enterochromaffin-like cells, gastrin cells and somatostatin cells in the rat stomach.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Enterochromaffin Cells; Female; Gastric Acid; Gastrins; Histamine; Histidine Decarboxylase; Lansoprazole; Omeprazole; Parietal Cells, Gastric; Rats; Rats, Inbred Strains; Somatostatin; Stomach | 1992 |
Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bethanechol Compounds; Dogs; Famotidine; Female; Gastric Acid; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Pentagastrin; Peptones; Pylorus; Rats; Rats, Inbred Strains | 1991 |
The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Analgesics, Non-Narcotic; Animals; Anti-Ulcer Agents; Carbachol; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gastric Acid; Gastric Fistula; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Histamine; Hydrogen-Ion Concentration; Imidazoles; Lansoprazole; Male; Microsomes; Omeprazole; Proton Pump Inhibitors; Pyridines; Stomach; Tetragastrin; Time Factors | 1999 |
Immunoelectron microscopic study for histamine in the gastric enterochromaffin-like cells of rats treated with the proton pump inhibitor lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Antibodies, Monoclonal; Cytoplasm; Enterochromaffin-like Cells; Enzyme Inhibitors; Exocytosis; Histamine; Lansoprazole; Male; Microscopy, Immunoelectron; Omeprazole; Proton Pump Inhibitors; Rats; Rats, Wistar; Secretory Vesicles; Vacuoles | 2003 |
Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Calcium; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Histamine; Humans; In Vitro Techniques; Lansoprazole; Male; Mammary Arteries; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Omeprazole; Ouabain; Phenylephrine; Potassium; Proton Pump Inhibitors; Radial Artery; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2006 |
1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Dithiothreitol; Gastric Acid; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Imidazoles; In Vitro Techniques; Kinetics; Lansoprazole; Ligation; Male; Potassium; Proton Pump Inhibitors; Pylorus; Pyrroles; Rats; Rats, Sprague-Dawley; Stomach; Sulfonamides; Swine | 2010 |
A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Cimetidine; Dogs; Gastric Acid; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Histamine; Histamine Agonists; Hydrogen-Ion Concentration; Lansoprazole; Male; Potassium; Proton Pump Inhibitors; Pyrroles; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors | 2011 |
Case of anaphylaxis to lansoprazole confirmed by histamine release test and oral provocation test.
Topics: Drug Hypersensitivity; Esophagitis, Peptic; Histamine; Histamine Release; Humans; Immunologic Tests; Lansoprazole; Middle Aged; Proton Pump Inhibitors | 2019 |
Acid suppressants use and risk of atherosclerotic cardiovascular disease in middle-aged and older adults.
Topics: Aged; Antihypertensive Agents; Atherosclerosis; Cardiovascular Diseases; Histamine; Humans; Lansoprazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Risk Assessment; Risk Factors | 2022 |